Kellie J. Nazemi
Doernbecher Children's Hospital
ORCID: 0000-0002-0293-2851Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Jennifer Cotter, Mehdi Touat, Jayne Vogelzang, Cecília Almeida e Sousa, Will Pisano +24 more
Papers
Driven by 4 papers — median percentile 63. Top paper: “Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002)”.
Kellie J. Nazemi, John R. Crawford, Lindsay Kilburn, Jane E. Minturn, Amar Gajjar +11 more
Jared Taitt, Javier Villanueva-Meyer, Erin R. Bonner, Takahide Nejo, Rishi R. Lulla +18 more
Jennifer Cotter, Mehdi Touat, Jayne Vogelzang, Cecília Almeida e Sousa, Will Pisano +24 more
Andrew Morin, Guisheng Zhao, Amy N. Allen, Patrick Flannery, Michael Glantz +13 more